Premphase Kit
Product Images NDC 0046-2575

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Premphase (NDC 0046-2575). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Prempro 01)

Chemical structure diagram of conjugated estrogens and medroxyprogesterone acetate, the active ingredients in Prempro tablets.*

FDA Label Image

Figure 1 (Prempro 02)

A line graph showing the percentage of patients across treatment cycles for two dosage groups of conjugated estrogens and medroxyprogesterone acetate (Prempro). The x-axis represents the treatment cycle number from 1 to 13, and the y-axis shows the percentage of patients from 0% to 100%. Two lines mark different dose groups, illustrating patient response progression over time.*

FDA Label Image

Figure 2 (Prempro 03)

Line graph showing percentage of patients over 13 cycles for three doses of conjugated estrogens and medroxyprogesterone acetate (0.625/2.5, 0.45/1.5, 0.3/1.5 mg). Percent patients (vertical axis) range from 0 to 100; cycles (horizontal axis) from 1 to 13. Each dose is represented by distinct markers with increasing trends over cycles.*

FDA Label Image

Figure 3 (Prempro 04)

A cumulative distribution plot showing percent change from baseline in spine bone mineral density (BMD) on the x-axis and cumulative percent of subjects on the y-axis. The graph compares effects of different Prempro dosage combinations (0.625/2.5, 0.45/1.5, 0.3/1.5) and placebo on spine BMD changes over time.*

FDA Label Image

Figure 4 (Prempro 05)

A line graph showing adjusted percent change from baseline over multiple cycles (0, 6, 13, 19, 26) comparing different dosages of Prempro (0.625/2.5, 0.45/1.5, 0.3/1.5 mg) versus placebo. The y-axis represents adjusted percent change from baseline, spanning from -4 to 5%.*

FDA Label Image

Logo (Prempro 06)

FDA Label Image

Logo (Prempro 06a)

FDA Label Image

Principal Display Panel (28 Tablet 0.625 mg / 5 mg Blister Pack)

Premphase tablets blister card showing 14 maroon tablets each with 0.625 mg conjugated estrogens and 14 light-blue tablets each with 0.625 mg conjugated estrogens and 5 mg medroxyprogesterone acetate. The label includes day-by-day tablet arrows for a 28-day regimen and instructions to take one maroon tablet daily for 14 days followed by one light-blue tablet daily for the next 14 days. The labeler is Wyeth Pharmaceuticals LLC, a Pfizer subsidiary.*

FDA Label Image

Principal Display Panel (Kit Carton)

Premphase (conjugated estrogens/medroxyprogesterone acetate) sugar-coated tablets packaging label from Pfizer. The package contains 28 tablets: 14 maroon tablets of 0.625 mg conjugated estrogens and 14 light-blue tablets of 0.625 mg conjugated estrogens/5 mg medroxyprogesterone acetate. This is a blister card format for oral use.*

FDA Label Image

Principal Display Panel (0.3 mg / 1.5 mg Blister Card)

Prempro 0.3 mg / 1.5 mg sugar-coated tablets carton label showing a 28-tablet supply packaged by Wyeth Pharmaceuticals LLC, a Pfizer subsidiary. The label lists the active ingredients conjugated estrogens and medroxyprogesterone acetate, dosing directions, storage instructions, and includes a barcode alongside lot and expiration date placeholders. Four weekly dosage sections are indicated.*

FDA Label Image

Principal Display Panel (0.3 mg / 1.5 mg Blister Card Carton)

Prempro 0.3 mg / 1.5 mg conjugated estrogens and medroxyprogesterone acetate tablets sugar coated oral medication. Package contains one blister card of 28 tablets. Labeled by Wyeth Pharmaceuticals LLC, a Pfizer Inc. subsidiary, made in Ireland. Includes storage and usage instructions.*

FDA Label Image

Principal Display Panel (0.45 mg / 1.5 mg Blister Card)

Prempro 0.45 mg / 1.5 mg sugar-coated tablets label showing a 28-tablet package for oral use. The product contains conjugated estrogens and medroxyprogesterone acetate. The label includes Pfizer and Wyeth Pharmaceuticals LLC branding, dosage instructions, storage conditions, lot and expiration placeholders, and a barcode.*

FDA Label Image

Principal Display Panel (0.45 mg / 1.5 mg Blister Card Carton)

Prempro 0.45 mg / 1.5 mg conjugated estrogens and medroxyprogesterone acetate tablets, sugar coated oral dosage form. The carton states it contains 1 blister card of 28 tablets. The labeler is Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. The packaging includes storage instructions, a barcode, and the indication that the product is made in Ireland.*

FDA Label Image

Principal Display Panel (0.625 mg / 2.5 mg Tablet Blister Card)

Prempro 0.625 mg/2.5 mg tablet label for conjugated estrogens and medroxyprogesterone acetate, sugar-coated tablets. The label indicates 28 tablets with weekly dosage instructions for four weeks. It is distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc, made in Ireland. Storage conditions and caution notes are included.*

FDA Label Image

Principal Display Panel (0.625 mg / 2.5 mg Tablet Blister Card Carton)

Packaging label for Prempro 0.625 mg / 2.5 mg sugar-coated tablets containing conjugated estrogens and medroxyprogesterone acetate. The carton states it contains one blister card of 28 tablets. Distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., made in Ireland. Includes storage instructions and a barcode.*

FDA Label Image

Principal Display Panel (0.625 mg / 5 mg Tablet Blister Card)

Prempro 0.625 mg / 5 mg tablet label for conjugated estrogens and medroxyprogesterone acetate, sugar coated oral tablets. The label, by Wyeth Pharmaceuticals LLC, a Pfizer Inc subsidiary, includes dosage strength, directions for use, storage instructions, package count of 28 tablets for four weeks, manufacturing origin Ireland, and distributor information.*

FDA Label Image

Principal Display Panel (0.625 mg / 5 mg Tablet Blister Card Carton)

Prempro 0.625 mg / 5 mg tablets packaging label shows a blister card box containing 28 sugar-coated tablets. The label states the active ingredients as conjugated estrogens and medroxyprogesterone acetate. The product is distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., and made in Ireland. The label also includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.